慢性丙型肝炎血清脂联素水平及其相关因素
被引量：1
摘要
脂联素（adiponectin）是一种由脂肪细胞分泌的蛋白质，与TNF—α在靶组织中互相拮抗对方的作用，具有肝脏保护作用，其可能机制为诱导胰岛素敏感性、肝脏脂肪酸的氧化、减少脂肪酸的分泌以及抑制TNF-α的作用。本研究检测67例慢丙肝患者血清脂联素水平，分析其与BMI、生化指标、KNODELL评分、肝脂肪变程度、血清TNF—α水平之间的关系，冀期评价脂联素在慢性丙型肝炎中的作用。
同被引文献23
-
1Milan G, Granzotto M, Scarda A, et al. Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss. Obes Res, 2002, 10: 1095-1103.
-
2Fasshauer M, Kralisch S, Klier M, et al. Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. Biochem Biophys Res Commun, 2003, 301: 1045-1050.
-
3Simons PJ, van den Pangaart PS, Aerts JM, et al. Pro-inflammatory delipidizing cytokines reduce adiponectin secretion from human adipocytes without affecting adiponectin oligomerization. J Endocrinol, 2007, 192: 289-299.
-
4Aksoz K, Unsal B, Kirci A, et al. The relationship between chronic HCV infection and the level of plasma adiponectin. Turk J Gastroenterol, 2008, 19: 254-257.
-
5Aksoz K, Unsal B, Kirci A, et al. The relationship between chronic HCV infection and the level of plasma adiponectin. Turk J Gastroenterol, 2008, 19: 254-257.
-
6Tanaka N, Nagaya T, Komatsu M, et al. Insulin resistance and hepatitis C virus: a case-control study of non-obese, non-alcoholic and non-steatotic hepatitis virus carriers with persistently normal serum aminotransferase. Liver Int, 2008, 28:1104-1111.
-
7Wedemeyer I, Bechmann LP, Odenthal M, et al. Adiponectin inhibits steatotic CD95/Fas up-regulation by hepatocytes: therapeutic implications for hepatitis C. J Hepatol, 2009, 50: 140-149.
-
8Furusyo N, Sawayama Y, Maeda S, et al. High molecular weight form of adiponectin levels of Japanese patients with chronic hepatitis C virus infection. Hepatol Res, 2007, 37: 1052- 1061.
-
9Liu C J, Chen PJ, Jeng YM, et al. Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C. J Hepatol, 2005, 43: 235-242.
-
10Jonsson JR, Moschen AR, Hickman I J, et al. Adiponectin and its receptors in patients with chronic hepatitis C. J Hepatol, 2005, 43: 929-936.
-
1黄顺忠,凌永体,黄元东,农善华,蒙少福.纳洛酮对急性有机磷中毒者肝脏保护作用的研究[J].右江民族医学院学报,2005,27(1):1-2.
-
2谢杰荣,谢忠,温继育,冯丽萍.苦参素注射液对化疗所致肝损害的保护作用[J].中国基层医药,2006,13(8):1341-1342. 被引量：3
-
3杨春,肖永红,管小琴.拉米夫定治疗慢性乙型肝炎的肝组织病理学研究[J].重庆医科大学学报,2004,29(1):34-37. 被引量：2
-
4李绍南.蓝莓有益于肝纤维化的动物[J].心血管病防治知识,2010(9):43-43.
-
5王欣欣,孙琳,郎振为,孟忻,张世杰.CHB患者不同分级、分期肝组织中TGF-β1的表达研究[J].胃肠病学和肝病学杂志,2004,13(3):291-293. 被引量：1
-
6李旭宏,龚建平.甘氨酸对肝脏保护作用的研究进展[J].国外医学（消化系疾病分册）,2003,23(6):341-344. 被引量：2
-
7陈文友.纳洛酮对急性有机磷中毒者肝脏保护作用的研究[J].内蒙古中医药,2008,27(10X):9-9.
-
8赵桂鸣,邹焕文.乙肝病毒携带者肝组织学的改变[J].天津医药,2005,33(9):550-551. 被引量：25
-
9陈玉华,杨璐,陈晓铭,胡桂芳,武革.罗格列酮对2型糖尿病合并非酒精性脂肪肝病大鼠肝脏保护作用的研究[J].新医学,2010,41(3):174-176. 被引量：2
-
10饶慧瑛,魏来,赵景民,孙德贵,郭芳,马慧,房继莲,邵杰,张兰芳,孙焱,王豪.丙型肝炎病毒感染患者13～14年后病毒组织学随访观察[J].中华医学杂志,2005,85(17):1166-1170. 被引量：4
